|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Investment in ether, at fair value (cost $151,725,831, and $181,475,994, respectively) | |||||||||
| Receivable for investment in ether sold | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Payable for shares redeemed | |||||||||
| Accrued Sponsor fee | |||||||||
| Total liabilities | |||||||||
| Net assets | |||||||||
| Shares issued (in Shares) | |||||||||
| Shares outstanding (in Shares) | |||||||||
| Net Asset Value per Share (in Dollars per share) |
Loading...
